Hold ACN at 3-3.5% with $175 hard stop and structured add/trim triggers around $178-183 and $195-198
Hold ACN at 3-3.5% portfolio weight. The synthesis incorporates the Aggressive, Conservative, and Neutral analysts' positions: the structural floor ($25B cash, $1.78B net cash, $9.6B annual capital return, 24.4% ROE, 10.4% FCF yield, $9.6B buyback program) is too thick to trim into given the 9/15 trim already captured tactical reduction opportunity, while damaged technicals (200 SMA rejection at $196-198, MACD bearish cross, death cross posture), tightening macro (5%+ 10-year with 95% no-cut odds), and binary Q4 FY26 catalyst proximity justify not adding fresh capital. The Neutral analyst's execution framework is most actionable: 3.5% sizing, $175 hard stop, $178-183 add zone, and $198 failed breakout trim trigger provide structured discipline against passive bleeding. Probability-weighted: Base case ~55% at $190-205 range, Bull case ~25% at $220-240, Bear case ~20% at $170-180; expected return approximately flat to slightly positive with optionality on Q4 FY26 resolution.
| Position | Action |
|---|---|
| 3-3.5% portfolio position (post 9/15 trim) | Hold/maintain reduced exposure |
| $175 hard stop (7.6% downside cushion from $189.64) | Mandatory trim/exit on close below |
| Pullback to $178-183 with constructive momentum | Add incrementally |
| Close above $200 with volume >40M | Add position |
| Failed breakout at $195-198 with weakening momentum | Trim exposure |
| Breakdown below $175 on rising volume | Trim/exit |
Accenture's AI integration business is a tailwind, not a threat, and at 12.9x forward earnings with 17% growth and 10%+ FCF yield, the stock offers an asymmetric risk-reward setup as a temporarily mispriced quality compounder.
| Indicator | Value | Signal |
|---|---|---|
| close | 189.64 | neutral |
| 10-EMA | 187.17 | bullish |
| 50-SMA | 169.05 | bullish |
| 200-SMA | 198.02 | bearish |
| MACD | +4.77 | neutral |
| MACD Signal | +5.24 | neutral |
| MACD Histogram | -0.48 | bearish |
| RSI | 57.66 | neutral |
| Bollinger Mid | 186.08 | neutral |
| Bollinger Upper | 196.46 | bearish |
| Bollinger Lower | 175.71 | bullish |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Close above $200 with volume >40M
Then: Add position
AI disintermediation thesis is backwards — enterprises need Accenture MORE to extract value from AI spend
↩ rebuts: “AI chatbots and code-gen tools replacing consulting hours”
EV: +15.9% to +21.3% (target $220-230 vs. $189.64 entry) · concedes: AI narrative overhang creates near-term sentiment pressure; Hawkish Fed is a tough macro backdrop; DOJ settlement creates minor noise despite being immaterial; Morgan Stanley $175 price target is below current $189.64 price; Demand environment described as 'muted but stable'; DOJ settlement mentioned as reputational overhang by bear
Accenture's valuation multiple has been reset by the market because fundamental deterioration — not opportunity — explains the depressed multiple; the bear case is not priced in but IS the current reality.
→ vs conservative: Death cross is narrative anchoring on lagging data; smart money already repositioning after 60% recovery
| ATR | 6.93 | neutral |
| VWMA | 187.25 | neutral |
Support: 175.71 · 169.05 | Resistance: 196.46 · 198.02 · 200
ACN shows mixed technical signals with short- and medium-term bullish trends (price above 50-SMA by ~$20) but long-term bearish pressure (price below 200-SMA by ~$8). The MACD has a bearish crossover with histogram at -0.48, RSI is neutral-bullish at 57.66, and price sits just above the 10-EMA and VWMA near $187. The stock has recovered from a June 2026 split-adjusted low of ~$116 (~60% rally) but faces overhead resistance at the 200-SMA and Bollinger upper band confluence ($196–198). Risk-reward at $189.64 is slightly negative with ~4.5% upside to resistance vs ~7.7% downside to support.
Market Capitalization
$116.05 B
Share Price (implied from PE × EPS)
~$189.65
52-Week High
$291.09
52-Week Low
$118.15
50-Day MA
$168.13
200-Day MA
$201.09
P/E (TTM)
15.16x
Forward P/E
12.92x
PEG Ratio
1.42
P/B
3.64x
EPS (TTM)
$12.51
Forward EPS
$14.68
Dividend Yield
3.37%
Beta
1.09
Revenue FY22
$61,594M
Revenue FY23
$64,112M
Revenue FY24
$64,896M
Revenue FY25
$69,673M
Revenue TTM
$73.1B
Gross Profit FY22
$19,702M
Gross Profit FY23
$20,732M
Gross Profit FY24
$21,162M
Gross Profit FY25
$22,235M
Gross Margin FY22
32.0%
Gross Margin FY23
32.3%
Gross Margin FY24
32.6%
Gross Margin FY25
31.9%
Operating Income FY22
$9,367M
Operating Income FY23
$9,873M
Operating Income FY24
$10,034M
Operating Income FY25
$10,841M
Operating Margin FY22
15.2%
Operating Margin FY23
15.4%
Operating Margin FY24
15.5%
Operating Margin FY25
15.6%
Operating Margin TTM
16.96%
EBITDA FY22
$10,274M
EBITDA FY23
$10,248M
EBITDA FY24
$10,836M
EBITDA FY25
$11,867M
EBITDA Margin TTM
17.7%
Net Income FY22
$6,877M
Net Income FY23
$6,872M
Net Income FY24
$7,265M
Net Income FY25
$7,678M
Net Margin TTM
10.66%
Diluted EPS FY22
$10.71
Diluted EPS FY23
$10.77
Diluted EPS FY24
$11.44
Diluted EPS FY25
$12.15
Diluted EPS Q3-FY26
$3.80
Revenue CAGR FY22→FY25
4.2%
Revenue Growth FY25 YoY
+7.4%
Cash & Equivalents FY22
$7,890M
Cash & Equivalents FY23
$9,045M
Cash & Equivalents FY24
$5,004M
Cash & Equivalents FY25
$11,479M
Cash & Equivalents May-26
$10,165M
Total Assets FY22
$47,263M
Total Assets FY23
$51,245M
Total Assets FY24
$55,932M
Total Assets FY25
$65,395M
Total Assets May-26
$68,807M
Goodwill FY22
$13,133M
Goodwill FY25
$22,536M
Goodwill May-26
$25,323M
Long-Term Debt FY24
$79M
Long-Term Debt FY25
$5,034M
Long-Term Debt May-26
$5,029M
Total Debt FY25
$8,183M
Total Debt May-26
$8,389M
Total Equity FY25
$31,195M
Total Equity May-26
$31,891M
Debt/Equity FY25
~25%
Current Ratio FY25
1.42
Net Cash Position FY25
~$3.3B
Operating Cash Flow FY22
$9,541M
Operating Cash Flow FY23
$9,524M
Operating Cash Flow FY24
$9,131M
Operating Cash Flow FY25
$11,474M
Operating Cash Flow TTM
~$12,089M
CapEx FY25
$600M
Free Cash Flow FY22
$8,823M
Free Cash Flow FY23
$8,996M
Free Cash Flow FY24
$8,615M
Free Cash Flow FY25
$10,874M
Free Cash Flow TTM
~$12.1B
Free Cash Flow Margin TTM
16.5%
FCF Yield
~10.4%
Dividends Paid FY22
$2,457M
Dividends Paid FY25
$3,700M
Dividends Paid TTM
~$3,930M
Dividend Growth CAGR FY22→FY25
+14.5%
Buybacks FY24
$4,525M
Buybacks FY25
$4,619M
Buybacks TTM
~$5,668M
Net Business Acquisitions FY24
$6,583M
Net Business Acquisitions FY25
$1,471M
Interest Expense FY24
$59M
Interest Expense FY25
$229M
ROE TTM
24.4%
ROA TTM
10.9%
52-Week Drawdown
~35%
Goodwill/Equity FY25
~79%
Strengths
Concerns
No formal rating was assigned in this report. Accenture presents a "quality at a lower price" scenario with a forward P/E of 12.9x, 24.4% ROE, and ~10.4% FCF yield following a ~35% drawdown, though the stock is technically weak below both moving averages. Revenue growth accelerated to +7.4% in FY25 and TTM FCF of ~$12.1B supports ~$9.6B in annual capital returns (dividends + buybacks), but concerns around elevated goodwill (79% of equity), increased leverage ($5B+ debt issuance), and decelerating growth (4.2% CAGR vs pre-pandemic 8-10%) warrant caution without confirmed growth re-acceleration.
Macro: Hawkish macro environment with the Fed actively hiking rates (Sept 16, 2026 rate hike) and 10-year Treasury yield at 5% (highest since 2007), creating direct multiple compression for high-quality compounders like ACN; Polymarket pricing 95% probability of NO Fed rate cuts in 2026; US recession odds at 10% (+3pp in one week), rising but remaining low; Jamie Dimon notes uncertainty on inflation; ACN trades with elevated uncertainty (options-implied 12-month range of $123–$308).